On the public citation graph

Does Race Play a Role in Complications and Outcomes of Philadelphia Chromosome-Negative Myeloproliferative Neoplasms?

https://doi.org/10.1016/j.hemonc.2021.01.005

0 signed · 28 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.

Claim with ORCID

Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.

See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1001/jamaoncol.2015.89openalex-snapshot

Myeloproliferative Neoplasms

inferredcites →https://doi.org/10.1007/s00277-016-2621-2openalex-snapshot

Diagnosis, prevention, and management of bleeding episodes in Philadelphia-negative myeloproliferative neoplasms: recommendations by the Hemostasis Working Party of the German Society of Hematology and Medical Oncology (DGHO) and the Society of Thrombosis and Hemostasis Research (GTH)

inferredcites →https://doi.org/10.1016/j.clml.2016.02.036openalex-snapshot

Outcome Disparities in Caucasian and Non-Caucasian Patients With Myeloproliferative Neoplasms

inferredcites →https://doi.org/10.1016/j.patbio.2004.02.007openalex-snapshot

A prospective analysis of thrombotic events in the European collaboration study on low-dose aspirin in polycythemia (ECLAP)

inferredcites →https://doi.org/10.1038/leu.2011.314openalex-snapshot

Venous thromboembolism in patients with essential thrombocythemia and polycythemia vera

inferredcites →https://doi.org/10.1038/s41408-017-0035-6openalex-snapshot

Risk factors for arterial versus venous thrombosis in polycythemia vera: a single center experience in 587 patients

inferredcites →https://doi.org/10.1056/nejm199504273321704openalex-snapshot

Hydroxyurea for Patients with Essential Thrombocythemia and a High Risk of Thrombosis

inferredcites →https://doi.org/10.1111/bjh.14061openalex-snapshot

Incidence and patient survival of myeloproliferative neoplasms and myelodysplastic/myeloproliferative neoplasms in the United States, 2001–12

inferredcites →https://doi.org/10.1111/ejh.13232openalex-snapshot

Characteristics and outcomes of young adults with Philadelphia‐negative myeloproliferative neoplasms

inferredcites →https://doi.org/10.1182/blood-2009-08-238956openalex-snapshot

Thrombosis in primary myelofibrosis: incidence and risk factors

inferredcites →https://doi.org/10.1182/blood-2012-07-444067openalex-snapshot

Development and validation of an International Prognostic Score of thrombosis in World Health Organization–essential thrombocythemia (IPSET-thrombosis)

inferredcites →https://doi.org/10.1182/blood-2013-03-460154openalex-snapshot

Myeloproliferative neoplasms and thrombosis

inferredcites →https://doi.org/10.1182/blood-2016-03-643544openalex-snapshot

The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia

inferredcites →https://doi.org/10.1182/blood-2017-06-782037openalex-snapshot

Myeloproliferative neoplasms: from origins to outcomes

inferredcites →https://doi.org/10.1182/blood.v26.5.657.657openalex-snapshot

An Epidemiological Study of Polycythemia Vera

inferredcites →https://doi.org/10.1186/s12885-019-5387-9openalex-snapshot

A systematic review and meta-analysis of the prevalence of thrombosis and bleeding at diagnosis of Philadelphia-negative myeloproliferative neoplasms

inferredcites →https://doi.org/10.1186/s12885-019-6045-yopenalex-snapshot

Lipid accumulation impairs natural killer cell cytotoxicity and tumor control in the postoperative period

inferredcites →https://doi.org/10.1200/jco.2005.07.062openalex-snapshot

Vascular and Neoplastic Risk in a Large Cohort of Patients With Polycythemia Vera

inferredcites →https://doi.org/10.1200/jco.2014.57.6652openalex-snapshot

Risk and Cause of Death in Patients Diagnosed With Myeloproliferative Neoplasms in Sweden Between 1973 and 2005: A Population-Based Study

inferredcites →https://doi.org/10.7326/m17-0028openalex-snapshot

Risk for Arterial and Venous Thrombosis in Patients With Myeloproliferative Neoplasms

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.4670506openalex-extracted

Agent Orange Exposure Enhances the Increased Risk of Cardiovascular Disease in Veterans with Myeloproliferative Neoplasms

inferred← citeshttps://doi.org/10.1002/ajh.27438openalex-snapshot

Risk of myeloproliferative neoplasms among U.S. Veterans from Korean, Vietnam, and Persian Gulf War eras

inferred← citeshttps://doi.org/10.1007/s00277-024-05894-7openalex-snapshot

Socio-demographic determinants of myelofibrosis outcomes in an underserved center and the SEER national database

inferred← citeshttps://doi.org/10.1016/s2352-3026(21)00303-3openalex-snapshot

Racial and ethnic survival disparities in patients with haematological malignancies in the USA: time to stop ignoring the numbers

inferred← citeshttps://doi.org/10.1038/s41375-026-03124-9openalex-snapshot

Incidence, prevalence, and survival outcomes of patients with myeloproliferative neoplasms in the United States: a Surveillance, Epidemiology, and End Results (SEER) database analysis, years 2000–2021

inferred← citeshttps://doi.org/10.1080/10428194.2022.2113531openalex-snapshot

Patient-reported outcomes of patients with myelofibrosis or essential thrombocythemia enrolled in the MOST study

inferred← citeshttps://doi.org/10.1182/bloodadvances.2022009611openalex-snapshot

Black African-American patients with primary myelofibrosis: a comparative analysis of phenotype and survival

inferred← citeshttps://doi.org/10.3324/haematol.2023.284921openalex-snapshot

CXCL8 and its cognate receptors CXCR1/CXCR2 in primary myelofibrosis

Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.